A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.

MLA

Patra, Nabanita, et al. “A Novel Epoxypropoxy Flavonoid Derivative and Topoisomerase II Inhibitor, MHY336, Induces Apoptosis in Prostate Cancer Cells.” European Journal of Pharmacology, vol. 658, no. 2–3, May 2011, pp. 98–107. EBSCOhost, https://doi.org/10.1016/j.ejphar.2011.02.015.

APA

Patra, N., De, U., Kang, J.-A., Kim, J. M., Ahn, M. Y., Lee, J., Jung, J. H., Chung, H. Y., Moon, H. R., & Kim, H. S. (2011). A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells. European Journal of Pharmacology, 658(2–3), 98–107. https://doi.org/10.1016/j.ejphar.2011.02.015

Chicago

Patra, Nabanita, Umasankar De, Jin-Ah Kang, Ji Mim Kim, Mee Young Ahn, Jaewon Lee, Jee H Jung, Hae Young Chung, Hyung Ryong Moon, and Hyung Sik Kim. 2011. “A Novel Epoxypropoxy Flavonoid Derivative and Topoisomerase II Inhibitor, MHY336, Induces Apoptosis in Prostate Cancer Cells.” European Journal of Pharmacology 658 (2–3): 98–107. doi:10.1016/j.ejphar.2011.02.015.